Improvement of recurrent diabetic ketoacidosis due to danazol
article
OA: bronze
CC0
Abstract
Abstract Recurrent diabetic ketoacidosis (DKA) is a serious problem for the patient and the attending health care team. We report the first ease of Danazol (Winthrop Laboratories, Guildford, UK), a synthetic derivative of ethisterone to improve this condition.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (5)
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Review: The Mechanism of Action of Danazol, a Novel Steroid Derivative via openalex
- doi:10.1210/jcem-59-2-350 via openalex
- doi:10.1093/oxfordjournals.aje.a113577 via openalex
- doi:10.1007/bf00456113 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T10:20:28.369573+00:00
License: CC0
· commercial use OK